Biotricity
OTC: BTCYRedwood City, US · Founded 2012 · Nevada corporation
Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Biotricity was founded in 2012 by Waqaas Al-Siddiq.
WA
Waqaas Al-SiddiqCEO/Chairman
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 5 rounds · 2016–2024
▶$1MraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chester WhiteDirector
- David A. RosaDirector
- John AyanoglouExecutive Officer
- Waqaas Al-SiddiqExecutive Officer, Director
- Ronald McClurgDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Mar 2024
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.3MraisedAug 2020 · 24 investors · BiotechnologyRule 506(b)
▶$1.3MraisedAug 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David RosaDirector
- Steve SalmonDirector
- Patricia KennedyDirector
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Norman BettsDirector
- Offering amount
- $10M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- Sales commissions
- $1.2M
- Placement agents
- Paulson Investment Company
- First sale
- Jul 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$6MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedMar 2017 · BiotechnologyRule 506(b)
▶$1.2MraisedMar 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $1.2M
- Minimum investment
- $50K
- Sales commissions
- $100K
- Placement agents
- Corinthian Partners LLC
- First sale
- Mar 2017
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$1.1MraisedAug 2016 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedAug 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- Norman M. Betts, M.D.Director
- David A. RosaDirector
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapWHOOP360 shared keywordsWHOOP is a wearable health monitoring device that provides 24/7 tracking of sleep, strain, stress, and heart health metrics to help users optimize their fitness and wellness.
Oura357 shared keywordsOura Ring is a wearable smart ring that collects and analyzes 50+ personal health metrics to provide insights on sleep, fitness, and wellness for individual users.
Bodyspec353 shared keywordsBodySpec provides DEXA scans that measure body fat percentage, lean muscle mass, visceral fat, and bone density, delivering a body composition report with an AI-powered dashboard and voice consultant. The company offers scans without a doctor's referral at 100+ locations across major US cities for consumers tracking their health and fitness.
Welltory347 shared keywordsWelltory is a health intelligence app that turns heart rate variability and over 100 biomarkers into personalized insights to help users monitor energy, recovery, and prevent burnout. Aimed at consumers wanting to understand their bodies, it uses proprietary algorithms validated through peer-reviewed research.
Ultrahuman330 shared keywordsUltrahuman makes wearable and consumer health devices — including the Ring AIR smart ring, continuous glucose monitoring, red light therapy, sleep monitors, and blood biomarker testing — paired with an app for sleep, metabolic, and recovery tracking. Its products target consumers and athletes focused on preventive health, fitness, and longevity.
Companies competing with Biotricity for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Biotricity do?
- Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
- Who founded Biotricity?
- Biotricity was founded by Waqaas Al-Siddiq in 2012.
- How much funding has Biotricity raised?
- Biotricity has disclosed $10.6M raised across 5 rounds.
- Where is Biotricity headquartered?
- Biotricity is headquartered in Redwood City, US.